Experimental GLP-1 pill helped people with obesity lose weight, Eli Lilly says

(CNN)– Eli Lilly hopes to be the first drugmaker to offer an effective GLP-1 in pill form to treat obesity.

The company already makes the injectable GLP-1 drugs Zepbound, Mounjaro and Trulicity.

Now, Eli Lilly says its experimental GLP-1 pill is a success after the first phase-three trial.

The company said more than 3,000 adults on the experimental oral medication lowered their weight by an average of 12% after 72 weeks.

The pill was also tied to lower markers of cardiovascular risk, including cholesterol and blood pressure.